Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2006-01-26
2011-11-22
Weddington, Kevin E (Department: 1629)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S458000, C514S474000, C514S866000
Reexamination Certificate
active
08063024
ABSTRACT:
The present invention provides antioxidant compositions comprising S-adenosylmethionine (SAMe), vitamin E and vitamin C and uses thereof for the treatment of liver injury and insulin resistance.
REFERENCES:
patent: 3893999 (1975-07-01), Fiecchi
patent: 4057686 (1977-11-01), Fiecchi
patent: 5078989 (1992-01-01), Ando et al.
patent: 5137723 (1992-08-01), Yamamoto et al.
patent: 6596701 (2003-07-01), Schwartz et al.
patent: 2004/0220118 (2004-11-01), Bland et al.
patent: 2004/0254095 (2004-12-01), Martin et al.
patent: WO 02092105 (2002-11-01), None
Faure et al., “Vitamin E Improves the Free Radical Defense System Potential and Insulin Sensitivity of Rats Fed High Fructose Diets”, The Journal of Nutrition vol. 127, No. 1, pp. 103-107 (1997).
Deulofeu et al., 2000, “5-adenosylmethionine prevents hepatic tocopherol depletion in carbon tetrachloride-injured rats,”Clin. Sci. 99: 315-320.
Baron et al., 1999, “Role of glutathione, lipid peroxidation and antioxidants on acute bile-duct obstruction in the rat.”Biochimica et Biophysica Acta1472: 173-180.
Bates et al., 1997, “Antioxidant status and lipid peroxidation in diabetic pregnancy.”British Journal of Nutrition78: 523-532.
Bruck et al., 2001, “Prevention of hepatic cirrhosis in rats by hydroxyl radical scavengers.”Journal of Hepatology35: 457-464.
Bruck et al., 2004, “Melatonin inhibits nuclear facot kappa B activation and oxidative stress and protects against thioacetamide induced liver damage in rats.”Journal of Hepatology40: 86-93.
Ceriello, 1999, “Hyperglycaemia: the bridge between non-enzymatic glycation and oxidative stress in the pathogenesis of diabetic complications.”Diab. Nutr. Metab. 12: 42-46.
Evans et al., 1997, “Antioxidant properties of S-adenosyl-L-methionine: a proposed addition to organ storage fluids.”Free Radic Biol Med23(7): 1002-1008.
Fang et al., 2002, “Free radicals, antioxidants, and nutrition.”Nutrition18 (10): 872-879.
Flora et al., 2003, “Beneficial effect of combined administration of some naturally occurring antioxidants (vitamins) and thiol chelators in the treatment of chronic lead intoxication.”Chemico-Biological Interactions145: 267-280.
Garcia-Ruiz et al., 1995, “Feeding S-adenosyl-L-methionine attenuates both ethanol-induced depletion of mitochondrial glutathione.”Hepatology21(1): 207-14.
Graham et al., 1989, “Reduced glutathione effecs on α-Tocopherol concentration of rat liver lipid microsomes undergoing NADPH-dependent peroxidation.”Lipids24 (11): 909-914.
Guarino et al., 2003, “Hepatic glutathione and nitric oxide are critical for hepatic insulin-sensitizing.”Am J Phiol Gastrointest-Liver-Physiol284 (4): G588-94.
Halim et al., 1997, “Biochemical effect of antioxidants on lipids and liver function in experimentally-induced liver damage.”Ann Clin Biochem34: 656-663.
Jaeschke et al., 1988, “Reactive oxygen species during ischemia-reflow injury in isolated perfused rat liver.”J. Clin Invest. 81(4): 1240-6.
Jaeschke et al., 2003, “The role of oxidant stress and reactive nitrogen species in acetaminophen hepatotoxicity.”Toxicology Letters144:279-288.
Lautt, 2003, “Practice and principles of pharmacodynamic determination of HISS-dependent and HISS-independent insulin action: Methods to quantitate mechanisms of insulin resistance.”Medicinal.Research Reviews23(1): 1-14.
Lautt, 2004, “A new paradigm for diabetes and obesity: the hepatic insulin sensitizing substance (HISS) hypothesis.”J. Pharmacol. Sci. 95: 9-17.
Lautt et al., 1998, “Rapid insulin sensitivity test (RIST).”Can. J. Physiol. Pharamcol. 76:1080-1086.
Lautt et al., 1999, “The HISS story overview: a novel hepatic neurhumoral regulation of peripheral insulin sensitivity in health and diabetes.”Can. J. Physiol. Pharamcol. 77: 553-562.
Lieber, 1999, “Role of S-adenosyl-L-methionine in the treatment of liver diseases.”Journal of Hepatology30: 1155-1159.
Lieber et al., 1990, “S-adenosyl-L-methionine attenuates alcohol-induced liver injury in the baboon.”Hepatology11(2): 165-72.
Locatelli et al., 2003, “Oxidative stress in end-stage renal disease: an emerging threat to patient outcome.”Nephrol Dial Transplant18: 1272-1280.
McDonough, 2003, “Antioxidant nutrients and alcohol.”Toxicology189: 89-97.
Mato et al., 1999, “S-Adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial.”Journal of Hepatology30: 1081-1089.
Parola et al., 1992, “Vitamin E dietary supplementation protets against carbon tetrachloride-induced chronic liver damage and cirrhosis.”Hepatology16(4): 1014-21.
Scholz et al., 1997, “Glutathione-dependent factors and inhibition of rat liver microsomal lipid peroxidation.”Free Radical Biology&Medicine23(5): 815-828.
Singh et al., 1994, “Plasma levels of antioxidant vitamins and oxidative stress in patients with acute myocardial infarction.”Acta Cardiologica49(5): 441-452.
Stehbens et al., 2003, “Oxidative stress, toxic hepatitis, and antioxidants with particular emphasis on zinc.”Exp Mol Pathol75: 265-276.
Vendemiale et al., “An update on the role of free radicals and antioxidant defense in human disease.”Int. J. Clin. Lab. Res. 29: 49-55, 1999.
Lautt Wilfred Wayne
Ming Zhi
Merchant & Gould P.C.
University of Manitoba
Weddington Kevin E
LandOfFree
Use of S-adenosylmethionine, vitamin E, and vitamin C for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of S-adenosylmethionine, vitamin E, and vitamin C for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of S-adenosylmethionine, vitamin E, and vitamin C for... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4298719